XML 44 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Net Loss per Common Share (Tables)
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Anti-dilutive securities excluded from the computation of earnings per share

The following potentially dilutive securities were excluded from the computation of earnings per share as of June 30, 2020 and 2019 because their effects would be anti-dilutive:

 

 

 

June 30,

 

(in thousands, except share data)

 

2020

 

 

2019

 

Stock options

 

 

1,640

 

 

 

1,667

 

Common stock warrants - equity

 

 

4,051,499

 

 

 

6,004

 

Common stock warrants - liabilities

 

 

 

 

 

179

 

Common stock reserved for conversion of preferred shares

 

 

2,595,087

 

 

 

 

Assumed conversion of convertible notes

 

 

146,288

 

 

 

480

 

Total

 

 

6,794,514

 

 

 

8,329

 

Calculation of net loss and number of shares used to compute basic and diluted earnings per share

However, in certain periods in which the exercise price of the warrants was less than the last reported sales price of Delcath’s common stock on the final trading day of the period and there is a gain recorded pursuant to the change in fair value of the warrant derivative liability, the impact of gains related to the mark-to-market adjustment of the warrants outstanding at the end of the period is reversed and the treasury stock method is used to determine diluted earnings per share.

 

 

 

The following table reconciles net loss per share for the three and six months ended June 30, 2020 and 2019:

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

(in thousands, except share data)

2020

 

 

2019

 

 

2020

 

 

2019

 

Net loss

$

(4,275

)

 

$

(5,959

)

 

$

(12,136

)

 

$

(13,853

)

Deemed dividend for triggering of warrant down round feature

 

(55

)

 

 

 

 

 

(55

)

 

 

 

Net loss attributable to common stockholders

$

(4,330

)

 

$

(5,959

)

 

$

(12,191

)

 

$

(13,853

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding - basic*

 

2,273,187

 

 

 

101,862

 

 

 

1,171,994

 

 

 

102,956

 

Weighted average shares outstanding - diluted*

 

2,273,187

 

 

 

101,862

 

 

 

1,171,994

 

 

 

102,956

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share - basic*

$

(1.90

)

 

$

(58.50

)

 

$

(10.40

)

 

$

(134.55

)

Net loss per share - diluted*

$

(1.90

)

 

$

(58.50

)

 

$

(10.40

)

 

$

(134.55

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* reflects, one-for-seven hundred (1:700) reverse stock split effected on December 24, 2019.

 

 

 

Summary of reconciliation of weighted average shares outstanding calculation The following table provides a reconciliation of the weighted average shares outstanding calculation for the three and six months ended June 30, 2020 and 2019:

 

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Weighted average shares issued

 

2,038,297

 

 

 

25,587

 

 

 

1,054,549

 

 

 

26,681

 

Weighted average pre-funded warrants

 

234,890

 

 

 

76,275

 

 

 

117,445

 

 

 

76,275

 

Weighted average shares outstanding

 

2,273,187

 

 

 

101,862

 

 

 

1,171,994

 

 

 

102,956